Hexagon Capital Partners’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-163	Closed	-$1.06K	–	1655
2025 Q1	$1.06K	Hold	163	–	–	﹤0.01%	1539
2024 Q4	$1.2K	Buy	163 +33	+25%	+$260	﹤0.01%	1529
2024 Q3	$974	Sell	130 -1	-0.8%	-$9	﹤0.01%	1334
2024 Q2	$1.17K	Sell	131 -6	-4%	-$58	﹤0.01%	1245
2024 Q1	$1.39K	Sell	137 -39	-22%	-$397	﹤0.01%	1224
2023 Q4	$1.77K	Sell	176 -140	-44%	-$1.28K	﹤0.01%	1152
2023 Q3	$2.96K	Sell	316 -442	-58%	-$6.3K	﹤0.01%	999
2023 Q2	$18.6K	Buy	758 +82	+12%	+$2.06K	﹤0.01%	581
2023 Q1	$15.7K	Sell	676 -143	-17%	-$3.66K	﹤0.01%	617
2022 Q4	$20.7K	Buy	819 +356	+77%	+$8.73K	0.01%	536
2022 Q3	$9K	Buy	463 +143	+45%	+$3.63K	﹤0.01%	814
2022 Q2	$8K	Buy	+320	New	+$7.47K	﹤0.01%	709
2022 Q1	–	Sell	-286	Closed	-$12K	–	991
2021 Q4	$12K	Buy	+286	New	+$11.2K	﹤0.01%	586